Consumer Groups, AAI Push Pay-For-Delay Ban

Law360, New York (January 11, 2010, 6:55 PM EST) -- The American Antitrust Institute, together with a coalition of consumer groups, is urging lawmakers to include a ban on pay-for-delay pharmaceutical patent settlements in the final version of health care reform legislation.

In a letter sent to House Speaker Nancy Pelosi, D-Calif., and Senate Majority Leader Harry Reid, D-Nev., Monday, the groups argue that banning the exclusion payments, coupled with an effort to revise the incentive structures for generic drugmakers, would help make prescription drugs more affordable.

“Attacking the exclusion payment problem is a critical element...
To view the full article, register now.